MICHAEL JOHNSON to Cardiovascular Diseases
This is a "connection" page, showing publications MICHAEL JOHNSON has written about Cardiovascular Diseases.
Connection Strength
0.626
-
Patterns of Lipid Lowering Therapy Use Among Older Adults in a Managed Care Advantage Plan in the United States. J Pharm Pract. 2024 Feb; 37(1):123-131.
Score: 0.322
-
Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease. Am J Manag Care. 2004 Dec; 10(12):926-32.
Score: 0.093
-
Risk of incident cardiovascular events with disease-modifying anti-rheumatic drugs among adults with rheumatoid arthritis: a nested case-control study. Clin Rheumatol. 2024 Jan; 43(1):103-116.
Score: 0.085
-
Enhancing Statin Adherence Using a Motivational Interviewing Intervention and Past Adherence Trajectories in Patients with Suboptimal Adherence. J Manag Care Spec Pharm. 2019 Oct; 25(10):1053-1062.
Score: 0.065
-
Risk of serious cardiac events in older adults using antipsychotic agents. Am J Geriatr Pharmacother. 2011 Apr; 9(2):120-32.
Score: 0.036
-
Therapeutic goal attainment in patients with hypertension and dyslipidemia. Med Care. 2006 Jan; 44(1):39-46.
Score: 0.025